Drugs / bone marrow mesenchymal stromal cells-derived extracellular vesicles
bone marrow mesenchymal stromal cells-derived extracellular vesicles
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06202547 | Feb 2023 → Oct 2024 | primary ovarian failure | Royan Institute | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bone marrow mesenchymal stromal cells-derived extracellular vesicles | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06202547 ↗ |
| Route | Other | “intraovarian injection of MSC-EVs” NCT06202547 ↗ |